Transgenic approaches that increase TDP-43 expression in model organisms (rodents, C. elegans and Drosophila) are sufficient to drive neurodegeneration, suggesting that increased levels of TDP-43 protein can accelerate progression of ALS and possibly other neurodegenerative conditions [28, 29]. Here, TARDBP is linked to amyotrophic lateral sclerosis.